Literature DB >> 32116030

Synthesis of quinoline derivatives as potential cysteine protease inhibitors.

Marina Ms Andrade1, Luan C Martins2, Gabriel Vl Marques1, Carla A Silva3, Gilson Faria3, Sérgio Caldas3, Janete Sc Dos Santos3, Sophie Y Leclercq3, Vinícius G Maltarollo1, Rafaela S Ferreira2, Renata B Oliveira1.   

Abstract

Aim: Cysteine proteases are important molecular targets involved in the replication, virulence and survival of parasitic organisms, including Trypanosoma and Leishmania species. Methodology & results: Analogs of the 7-chloro-N-[3-(morpholin-4-yl)propyl]quinolin-4-amine were synthesized and their inhibitory activity against the enzymes cruzain and rhodesain as well as against promastigotes forms of Leishmania species and epimastigotes forms of Trypanosoma cruzi were evaluated. Five compounds showed activity against both enzymes with half maximal inhibitory concentration (IC50) values ranging from 23 to 123 μM. Among these, compounds 3 and 4 displayed leishmanicidal activity; compound 4 was the most promising with IC50 values <10 μM and no cytotoxicity for uninfected cells.
Conclusion: The results obtained indicate that cysteine proteases are likely to be the molecular target of compounds 3 and 4.

Entities:  

Keywords:  4-aminoquinolines; antiparasitic activity; cysteine protease

Mesh:

Substances:

Year:  2020        PMID: 32116030     DOI: 10.4155/fmc-2019-0201

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  4 in total

1.  Identification of megacerotonic acid and a quinazoline derivative from Universal Natural Product Database as potential inhibitors of Trypanosoma brucei brucei alternative oxidase: molecular docking, molecular dynamic simulation and MM/PBSA analysis.

Authors:  Rahma Muhammad Adamu; Bashiru Ibrahim; Mohammed Auwal Ibrahim; Emmanuel Oluwadare Balogun
Journal:  J Biomol Struct Dyn       Date:  2021-11-23       Impact factor: 5.235

2.  Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.

Authors:  Aline Cavalcanti de Queiroz; Gisele Barbosa; Victória Regina Thomaz de Oliveira; Hélio de Mattos Alves; Marina Amaral Alves; Vanessa Carregaro; João Santana da Silva; Eliezer Jesus Barreiro; Magna Suzana Alexandre-Moreira; Lidia Moreira Lima
Journal:  PLoS One       Date:  2022-06-06       Impact factor: 3.752

Review 3.  Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.

Authors:  Jianbo Sun; Hui Zhong; Kun Wang; Na Li; Li Chen
Journal:  Acta Pharm Sin B       Date:  2021-03-04       Impact factor: 11.413

4.  Saccharobisindole, Neoasterric Methyl Ester, and 7-Chloro-4(1H)-quinolone: Three New Compounds Isolated from the Marine Bacterium Saccharomonospora sp.

Authors:  Sohee Kim; Tu Cam Le; Sang-Ah Han; Prima F Hillman; Ahreum Hong; Sunghoon Hwang; Young Eun Du; Hiyoung Kim; Dong-Chan Oh; Sun-Shin Cha; Jihye Lee; Sang-Jip Nam; William Fenical
Journal:  Mar Drugs       Date:  2021-12-29       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.